Myriad Genetics (0K3W.L) Stock Price

$6.07 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    2

  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Myriad Genetics, AI stock picks, stock alerts and much more.

Sign up

0K3W.L AI Stock Analysis

AI stock analysis for 0K3W.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Myriad Genetics (0K3W.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Myriad Genetics (0K3W.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Myriad Genetics (0K3W.L), currently trading at $6.07, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0K3W.L

LSE

  • Myriad Genetics, Inc.

  • Symbol

    0K3W.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    564.4M

Similar Stocks

0QZU.L Vertex Pharmaceuticals Incorporated
0QZU.L		 $398.5
0.5%
7
0K6R.L Neurocrine Biosciences
0K6R.L		 $136.1
1.2%
7
0IGA.L Emergent BioSolutions Inc.
0IGA.L		 $9.46
2.9%
4
0H7R.L Abeona Therapeutics Inc.
0H7R.L		 $7.25
1.7%
5
0LSZ.L Walgreens Boots Alliance
0LSZ.L		 $12.17
0.5%
5

News

A Pediatrician Sets The Record Straight On Autism

A Pediatrician Sets The Record Straight On Autism
April 24, 2025. Forbes
This One Vitamin Can Help Prevent Dementia (Especially For Women), Study Finds

This One Vitamin Can Help Prevent Dementia (Especially For Women), Study Finds
April 23, 2025. mindbodygreen.com
Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing

Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing
April 21, 2025. GlobeNewswire
The Goldman Sachs Group Has Lowered Expectations for Myriad Genetics (NASDAQ:MYGN) Stock Price

The Goldman Sachs Group Has Lowered Expectations for Myriad Genetics (NASDAQ:MYGN) Stock Price
April 20, 2025. ETF Daily News

0K3W.L Alternative Data

Web Traffic

Myriad Genetics receives an estimated 321824 monthly visitors to myriad.com.

  • Web Traffic

    321824

  • Change from Previous Month

    25.1%

  • 3 Month Change

    61.7%

  • YoY Change

    61.7%

Twitter Followers

Myriad Genetics has 6,762 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    6762

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.4%

Facebook Engagement

Myriad Genetics has engaged 6 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    6

  • Daily Change

    0%

  • 1 Month Change

    40%

  • 3 Month Change

    78.6%

Instagram Followers

Myriad Genetics has 3,551 Instagram Followers on its main Instagram account, up by 1.4% over the last month.

  • Instagram Followers

    3551

  • Daily Change

    0.1%

  • 1 Month Change

    1.4%

  • 3 Month Change

    3.3%

Youtube Subscribers

Myriad Genetics has 2,750 subscribers on its main Youtube channel, up by 0.4% over the last month.

  • Youtube Subscribers

    2750

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.1%

Reddit Mentions

Myriad Genetics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

97,446 are following Myriad Genetics on LinkedIn, up by 1.2% over the last month.

  • LinkedIn Followers

    97446

  • Daily Change

    1.2%

  • 1 Month Change

    1.2%

  • 3 Month Change

    3.3%

LinkedIn Employees

According to LinkedIn, Myriad Genetics has 2,725 employees, up by 0.1% over the last month.

  • LinkedIn Employees

    2725

  • Daily Change

    0.1%

  • 1 Month Change

    0.1%

  • 3 Month Change

    1.1%

Business Outlook

According to employee reviews, the business outlook among employees at Myriad Genetics is 54 out of 100 (neutral).

  • Business Outlook

    54

  • Change from Previous Month

    6.9%

  • 3 Month Change

    3.6%

  • YoY Change

    3.6%

News Mentions

Myriad Genetics was mentioned 3 times in the news yesterday.

  • News Mentions

    3

  • Daily Change

    25%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0K3W.L Financials

0K3W.L Key Metrics

  • Total Revenue

    $213.3M

  • Net Income

    -$22.1M

  • Earnings per Share

    -$0.24

  • Free cash flow

    -$5.6M

  • EBITDA

    -$2.2M

  • EBITDA Ratio

    -0.0103141

  • Total Assets

    $1.1B

0K3W.L 2-year Revenue & Income
0K3W.L 2-year Free Cash Flow

0K3W.L Technicals

0K3W.L SMA
0K3W.L RSI

FAQ

What's the current price of Myriad Genetics (0K3W.L) Stock?
The price of an Myriad Genetics (0K3W.L) share is $6.07.

What's the market cap of Myriad Genetics?
The current market cap of Myriad Genetics is 564.4M.

Should I buy or sell 0K3W.L?
Myriad Genetics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Myriad Genetics is better viewed as a hold or accumulate position while waiting for further developments.

Is Myriad Genetics a good investment?
The current analysis of Myriad Genetics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Myriad Genetics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Myriad Genetics (0K3W.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Myriad Genetics stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Myriad Genetics (0K3W.L) that investors often compare it to?
Myriad Genetics (0K3W.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.

What is the forecast for Myriad Genetics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Myriad Genetics' stock price to be around $6.09 in 2026. Starting from the current price of $6.07, this represents a 0.4% change in price, indicating a neutral outlook for the stock.

How to buy Myriad Genetics (0K3W.L) Stock?
Myriad Genetics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Myriad Genetics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.